Neurocrine Biosciences Stock Technical Analysis

NBIX Stock  USD 131.74  2.92  2.17%   
As of the 16th of April 2024, Neurocrine Biosciences secures the Risk Adjusted Performance of 0.0077, downside deviation of 1.6, and Mean Deviation of 1.18. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neurocrine Biosciences, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Neurocrine Biosciences, which can be compared to its peers in the industry. Please verify Neurocrine Biosciences jensen alpha and semi variance to decide if Neurocrine Biosciences is priced some-what accurately, providing market reflects its recent price of 131.74 per share. Given that Neurocrine Biosciences has jensen alpha of (0.02), we recommend you to check Neurocrine Biosciences's last-minute market performance to make sure the company can sustain itself at a future point.

Neurocrine Biosciences Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Neurocrine, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Neurocrine
  
Neurocrine Biosciences' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Neurocrine Biosciences Analyst Consensus

Target PriceAdvice# of Analysts
133.45Strong Buy29Odds
Neurocrine Biosciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Neurocrine analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Neurocrine stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Neurocrine Biosciences, talking to its executives and customers, or listening to Neurocrine conference calls.
Neurocrine Analyst Advice Details
Neurocrine Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Neurocrine Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neurocrine Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Neurocrine Biosciences Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Neurocrine Biosciences volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Neurocrine Biosciences Trend Analysis

Use this graph to draw trend lines for Neurocrine Biosciences. You can use it to identify possible trend reversals for Neurocrine Biosciences as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Neurocrine Biosciences price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Neurocrine Biosciences Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Neurocrine Biosciences applied against its price change over selected period. The best fit line has a slop of   0.01  , which may suggest that Neurocrine Biosciences market price will keep on failing further. It has 122 observation points and a regression sum of squares at 7.45, which is the sum of squared deviations for the predicted Neurocrine Biosciences price change compared to its average price change.

About Neurocrine Biosciences Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Neurocrine Biosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Neurocrine Biosciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Neurocrine Biosciences price pattern first instead of the macroeconomic environment surrounding Neurocrine Biosciences. By analyzing Neurocrine Biosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Neurocrine Biosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Neurocrine Biosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding59.7385.8184.9789.22
PTB Ratio5.866.75.776.13

Neurocrine Biosciences April 16, 2024 Technical Indicators

Most technical analysis of Neurocrine help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Neurocrine from various momentum indicators to cycle indicators. When you analyze Neurocrine charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether Neurocrine Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neurocrine Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurocrine Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurocrine Biosciences Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurocrine Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Neurocrine Stock please use our How to Invest in Neurocrine Biosciences guide.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for Neurocrine Stock analysis

When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Is Neurocrine Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurocrine Biosciences. If investors know Neurocrine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurocrine Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.648
Earnings Share
2.46
Revenue Per Share
19.315
Quarterly Revenue Growth
0.25
Return On Assets
0.0878
The market value of Neurocrine Biosciences is measured differently than its book value, which is the value of Neurocrine that is recorded on the company's balance sheet. Investors also form their own opinion of Neurocrine Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Neurocrine Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurocrine Biosciences' market value can be influenced by many factors that don't directly affect Neurocrine Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurocrine Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurocrine Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurocrine Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.